Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CHTOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
S100A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ILF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC27A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on